$147 Billion is the total value of Summit Rock Advisors, LP's 2 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DAWN | Exit | DAY ONE BIOPHARMACEUTICALS I | $0 | – | -25,751 | -100.0% | -0.40% | – |
| Exit | PLANET LABS PBC | $0 | – | -102,880 | -100.0% | -0.44% | – | |
| VT | Exit | VANGUARD INTL EQUITY INDEX Ftt wrld st etf | $0 | – | -66,600 | -100.0% | -4.10% | – |
Signatures
The EDGAR filing(s) were signed by:
- Asher Ailey — Chief Compliance Officer
- Summit Rock Advisors, LP holdings (13F-HR)
- Summit Rock Advisors, LP ownership history
- Summit Rock Advisors, LP portfolio value
- Summit Rock Advisors, LP filings
- Similar filers BETA
Compare quarterly holdings
Export Summit Rock Advisors, LP's holdings